[{"run_id":"20260906T231458-5fdd2fff","semester":"1272","observed_at":"2026-09-06 23:14:58.172943+00:00","record_version_id":"a7a31e74e189dcaba5f02e5f91501c212b8f820a3df1d82e1a08f9c981ec9e3c","course_id":"PHMSCI 765","course_uid":"course_89956a51efab87ddea383f50","catalog_version_id":"fde8818735034732bb4f15157229587245c57a30fae76245ea8bafd58ab4a1f6","course_number":765,"subjects":["PHMSCI"],"title":"PRINCIPLES OF ASSAY DEVELOPMENT","description":"Biochemical and spectrophotometric basis of molecular target assays in drug development. Different types of in vitro and cellular assays - how to choose the best one for the problem at hand. On-target and off-target activity. Uses and limitations of biochemical assays, biomarkers, and animal models. Challenges of translating pre-clinical data into clinical assumptions. Biases on non-quantifiable data. Critical evaluation of case studies and experimental assays on infectious diseases, auto-immune diseases, and CNS disorders. Designing proper assays according to drug development projects hypotheses.","requirements_text":"PHM SCI 759and (PHM SCI 757or762)","official_learning_outcomes_json":"[]"},{"run_id":"20260907T155543-ce3781c4","semester":"1272","observed_at":"2026-09-07 15:55:43.033547+00:00","record_version_id":"a7a31e74e189dcaba5f02e5f91501c212b8f820a3df1d82e1a08f9c981ec9e3c","course_id":"PHMSCI 765","course_uid":"course_89956a51efab87ddea383f50","catalog_version_id":"fde8818735034732bb4f15157229587245c57a30fae76245ea8bafd58ab4a1f6","course_number":765,"subjects":["PHMSCI"],"title":"PRINCIPLES OF ASSAY DEVELOPMENT","description":"Biochemical and spectrophotometric basis of molecular target assays in drug development. Different types of in vitro and cellular assays - how to choose the best one for the problem at hand. On-target and off-target activity. Uses and limitations of biochemical assays, biomarkers, and animal models. Challenges of translating pre-clinical data into clinical assumptions. Biases on non-quantifiable data. Critical evaluation of case studies and experimental assays on infectious diseases, auto-immune diseases, and CNS disorders. Designing proper assays according to drug development projects hypotheses.","requirements_text":"PHM SCI 759and (PHM SCI 757or762)","official_learning_outcomes_json":"[]"},{"run_id":"20261014T203208-0851c9a1","semester":"1274","observed_at":"2026-10-14 17:50:09.728220+00:00","record_version_id":"e1ea127a787b8e98afa4fa71fb53c78ab7b833ec298fb699663110d14b1914ff","course_id":"PHMSCI 765","course_uid":"course_89956a51efab87ddea383f50","catalog_version_id":"db6a1b38631c0a3c17d273c8302bb75147983b1680ba774b81c5c1e4b9478a1a","course_number":765,"subjects":["PHMSCI"],"title":"PRINCIPLES OF ASSAY DEVELOPMENT","description":"Biochemical and spectrophotometric basis of molecular target assays in drug development. Different types of in vitro and cellular assays - how to choose the best one for the problem at hand. On-target and off-target activity. Uses and limitations of biochemical assays, biomarkers, and animal models. Challenges of translating pre-clinical data into clinical assumptions. Biases on non-quantifiable data. Critical evaluation of case studies and experimental assays on infectious diseases, auto-immune diseases, and CNS disorders. Designing proper assays according to drug development projects hypotheses.","requirements_text":"PHM SCI 759and (PHM SCI 757or762)","official_learning_outcomes_json":"[{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Explain and apply the concepts, principles, and applications of the most commonly used biochemical and spectrophotometric assays used in drug development to quantify the activity of molecular targets and their modulators.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Recommend specific in vitro target assays based on the molecular target of choice and on the desired data output.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Compare and contrast cellular models, their applications and limitations, and propose assays that directly measure on-target activity.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Critique the use of various animal models when extrapolating pre-clinical data to clinical development.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Synthesize knowledge of biochemical, in vitro, and cellular assays to evaluate the validity, applications, and future developments of New Approach Methods (NAMs), according to the current FDA guidelines for animal use in research.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Analyze critically experimental approaches, assays outcomes, and their alignment to experimental hypothesis in drug development projects within the broad areas of infectious diseases, auto-immune diseases, and central nervous system (CNS) disorders.\"},{\"catalog_year\":\"2026-2027\",\"observed_at\":\"2026-10-14T17:51:12.655724+00:00\",\"source\":\"catalog\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\",\"term\":null,\"text\":\"Propose adequate experimental assays to support drug development projects hypotheses, demonstrating the limitations and the actual output of different in vitro, cellular, and animal models' assays.\"}]"}]